Modeling a complex disease: multiple sclerosis.

Area of Science:

• Neuroimmunology
• Neuropathology
• Disease Heterogeneity

Background:

• Multiple sclerosis (MS) is increasingly recognized as a heterogeneous syndrome, not a uniform disease.
• Distinct pathological patterns and etiologies are emerging, challenging earlier classifications like Devic's disease and opticospinal MS.
• Varied patient responses to immunomodulatory drugs (e.g., Rituximab, IFNβ) underscore the disease's complex mechanisms.

Purpose of the Study:

• To review current research on mouse models that recapitulate the distinct pathological patterns of multiple sclerosis.
• To highlight efforts in developing models that reflect the diverse etiologies and clinical manifestations of MS.
• To address the need for models that capture the late-stage neurodegenerative phase of MS, independent of adaptive immunity.

Main Methods:

• Analysis of biopsies and autopsies to identify distinct pathological patterns in MS.
• Observational studies on patient responses to targeted immunotherapies.
• Review of existing and novel mouse models designed to mimic specific MS phenotypes.

Main Results:

• Evidence supports MS heterogeneity, with distinct pathological subtypes and etiologies.
• Differential drug responses confirm varied underlying mechanisms in MS patients.
• The late neurodegenerative phase in severe MS involves mechanisms less responsive to current immunotherapies.

Conclusions:

• Understanding MS heterogeneity is crucial for developing effective treatments.
• Novel mouse models are essential for dissecting distinct MS pathways and testing new therapeutic strategies.
• Future research must address the neurodegenerative aspects of MS, potentially requiring non-immunomodulatory approaches.